S&P ASX All Technology

US Dollar vs AUD

Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

Get Started

ISPC iSpecimen Inc

1.99

-0.10 (-4.78%)

01 Feb 2025 - Closed

Delayed by 15 minutes

Form 3 - Initial statement of beneficial ownership of securities

iSpecimen (NASDAQ:ISPC)
Historical Stock Chart
From Jan 2025 to Feb 2025

Click Here for more iSpecimen Charts.

iSpecimen (NASDAQ:ISPC)
Historical Stock Chart
From Feb 2024 to Feb 2025

Click Here for more iSpecimen Charts.

iSpecimen Inc News

Form 3 - Initial statement of beneficial ownership of securities
Friday 31 January 2025 (1 day ago) • Edgar (US Regulatory)

Form 8-K - Current report
Friday 17 January 2025 (2 weeks ago) • Edgar (US Regulatory)

Form 8-K - Current report
Tuesday 31 December 2024 (1 month ago) • Edgar (US Regulatory)

Form 8-K - Current report
Saturday 21 December 2024 (1 month ago) • Edgar (US Regulatory)

Form 8-K - Current report
Saturday 14 December 2024 (2 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Friday 13 December 2024 (2 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Wednesday 13 November 2024 (3 months ago) • Edgar (US Regulatory)

iSpecimen Releases Cancer Biospecimen Offering; Orders Anticipated of Over $9,500,000 Annually
Thursday 7 November 2024 (3 months ago) • GlobeNewswire Inc.

iSpecimen Reports Third Quarter 2024 Results
Thursday 7 November 2024 (3 months ago) • GlobeNewswire Inc.

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Thursday 7 November 2024 (3 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Friday 1 November 2024 (3 months ago) • Edgar (US Regulatory)

iSpecimen Inc. Announces Closing of $5 Million Public Offering of Common Stock and Pre-Funded Warrants
Friday 1 November 2024 (3 months ago) • GlobeNewswire Inc.

More iSpecimen Inc News Articles

Commonwealth Bank Of Aus...

AUD vs US Dollar

Westpac Banking

Sterling vs AUD

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions